Amsterdam UMC, location VUmc: Neoplasm Metastasis trials

The registry lists 12 Neoplasm Metastasis studies with Amsterdam UMC, location VUmc as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver MetastasesRecruitingNCT06185556Phase 2/3
• COLLISION RELAPSE TrialRecruitingNCT05861505Phase 3
• Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative RadiotherapyNot yet recruitingNCT05808790Not applicable
• Evaluation of Fast, Same-day Delivery of Palliative Radiotherapy Without a Planning CT (FAST-METS)Status unknownNCT05288608
• COLLISION XL: Unresectable Colorectal Liver Metastases (3-5cm): Stereotactic Body Radiotherapy vs. Microwave AblationStatus unknownNCT04081168Not applicable
• COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal AblationStatus unknownNCT03088150Not applicable
• Local Radiotherapy Following Complete Resection of a Brain MetastasisTerminatedNCT02729558Not applicable
• Phase I Study on VEGF Vaccination in Metastatic Solid TumorsCompletedNCT02237638Phase 1
• Sentinel Lymph Node (SLN) in Colorectal Carcinoma (CRC) With a Near-infrared (NIR)-DyeCompletedNCT02122523Not applicable
• Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver MetastasesCompletedNCT02082782Phase 2
• Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory StudyTerminatedNCT01190241Not applicable
• Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung CancerCompletedNCT00536861Phase 1